GT BIOPHARMA, INC. Finite-Lived Patents, Gross
GT BIOPHARMA, INC. (GTBP) had Finite-Lived Patents, Gross of $642.00 thousand as of 2015-12-31, per its 10-K/A filed 2018-02-28.
Discontinued › Balance Sheet › Assets › Assets, Noncurrent › Intangible Asset, Excluding Goodwill, after Accumulated Amortization › Intangible Asset, Finite-Lived, after Accumulated Amortization › Intangible Asset, Finite-Lived, before Accumulated Amortization
us-gaap:FiniteLivedPatentsGross · last filed 2018-02-28
- 2015-12-31: Finite-Lived Patents, Gross $642.00K.
- 2014-12-31: Finite-Lived Patents, Gross $642.00K.
- 2014-09-30: Finite-Lived Patents, Gross $642.00K.
- 2014-06-30: Finite-Lived Patents, Gross $642.00K.
| Period end | Finite-Lived Patents, Gross |
|---|---|
| 2015-12-31 | $642.00K 10-K/A · filed 2018-02-28 |
| 2014-12-31 | $642.00K 10-K/A · filed 2018-02-28 |
| 2014-09-30 | $642.00K 10-Q · filed 2015-01-08 |
| 2014-06-30 | $642.00K 10-Q · filed 2015-01-08 |
| 2014-03-31 | $642.00K 10-Q · filed 2015-01-08 |
| 2013-12-31 | $642.00K 10-K · filed 2015-03-31 |
| 2013-09-30 | $642.00K 10-Q · filed 2014-12-17 |
| 2013-06-30 | $642.00K 10-Q · filed 2014-12-12 |
| 2013-03-31 | $642.00K 10-Q · filed 2014-12-10 |
| 2012-12-31 | $642.00K 10-K · filed 2015-01-08 |
| 2012-09-30 | $640.00K 10-Q · filed 2012-11-21 |
| 2012-06-30 | $640.00K 10-Q/A · filed 2012-09-13 |
| 2011-12-31 | $640.00K 10-K · filed 2014-11-18 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| ABEONA THERAPEUTICS INC. (ABEO) | United States | $0.312B | -5.63 |
| Vanda Pharmaceuticals Inc. (VNDA) | United States | $0.302B | -1.35 |
| Prelude Therapeutics Inc (PRLD) | United States | $0.318B | -7.01 |
| Evommune, Inc. (EVMN) | United States | $0.320B | -5.10 |
| STANDARD BIOTOOLS INC. (LAB) | United States | $0.297B | 3.80 |
| BridgeBio Oncology Therapeutics, Inc. (BBOT) | United States | $0.320B | -3.35 |
| ROCKET PHARMACEUTICALS, INC. (RCKT) | United States | $0.296B | -21.78 |
| Fulcrum Therapeutics, Inc. (FULC) | United States | $0.289B | -3.28 |
| Contineum Therapeutics, Inc. (CTNM) | United States | $0.289B | -4.40 |
| BioAge Labs, Inc. (BIOA) | United States | $0.333B | -11.88 |